FORW.PHARMA ADR/14
Depository Receipt · US34986J2042 · FWP · A2PV5H (XNCM)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of FORW.PHARMA ADR/14
No Price
Company Profile for FORW.PHARMA ADR/14 Depository Receipt
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Company Data
Name FORW.PHARMA ADR/14
Company Forward Pharma A/S
Symbol FWP
Website
https://www.forward-pharma.com
Primary Exchange 
NASDAQ CAPITAL MARKET
NASDAQ CAPITAL MARKET
WKN A2PV5H
ISIN US34986J2042
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO Claus Svendsen
Country Denmark
Currency EUR
Employees 0,0 T
Address Oestergade 24A, 1, Copenhagen K, 1100 Koebenhavn K
IPO Date 2014-10-15
Dividends from 'FORW.PHARMA ADR/14'
| Ex-Date | Dividend per Share |
|---|---|
| 12.09.2017 | 23,12 USD |
Stock Splits
| Date | Split |
|---|---|
| 06.12.2019 | 1:7 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | FWP |
More Shares
Investors who hold FORW.PHARMA ADR/14 also have the following shares in their portfolio:
